CARA Medical

CARA Medical

Software visualizing cardiac conduction for planning

Overview

CARA Medical builds software that helps doctors visualize the heart's electrical conduction system without surgery. Its tools use a patient’s CT angiography to create a personalized 3D map of the conduction pathways and provide navigation during procedures. The CARA Metis software generates a pre-procedure 3D overlay of the conduction system to aid planning, while CARA Atlas offers interactive, real-time 3D guidance during interventions. This setup supports conduction system pacing and structural heart procedures such as TAVR, TMVR, and TTVR. Compared with others, CARA Medical emphasizes patient-specific, non-invasive visualization derived from existing imaging to inform planning and execution, backed by a leadership team with deep experience in cardiac imaging and medical devices. The company’s goal is to reduce procedural risks and improve the precision of cardiac device placement, ultimately improving outcomes for patients undergoing complex heart procedures.

About CARA Medical

Simplify's Rating
Why CARA Medical is rated
C+
Rated C on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • CSP adoption accelerates, boosting demand for CARA's precision mapping.
  • Structural heart procedures like TAVR grow rapidly, needing conduction insights.
  • Breakthrough Designation in 2025 enables fast US commercial launch.

What critics are saying

  • Medtronic Affera captures electrophysiologists with March 2026 clearance.
  • Boston Scientific FARAPULSE bundles dominate pacing market in 12 months.
  • Abbott NavX upgrade commoditizes CARA software within 9 months.

What makes CARA Medical unique

  • CARA Metis generates personalized 3D conduction maps from CT angiography.
  • CARA Atlas overlays conduction models onto live fluoroscopic images.
  • FDA 510(k) clearance received February 2026 for noninvasive visualization.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

Yahoo Finance
Feb 25th, 2026
Cara Medical receives FDA clearance for noninvasive cardiac conduction system visualisation platform

Cara Medical has received FDA 510(k) clearance for the CARA System, a computed tomography angiography-based platform that provides noninvasive 3D visualisation of the cardiac conduction system. The system, which received FDA Breakthrough Device Designation last year, enables visualisation during structural heart and pacing procedures. The CARA System comprises two components: CARA Metis Simulator for preprocedural planning and CARA Atlas Navigator for intraprocedural guidance. The platform is intended for procedures including transcatheter aortic valve replacement and conduction system pacing. The system uses AI and machine learning algorithms to support CT segmentation and catheter detection, with outputs requiring physician review. Cara Medical plans to begin its US commercial launch in the coming months.

Recently Posted Jobs

Sign up to get curated job recommendations

CARA Medical is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →